| Date Checked | 2026-02-19 22:18:09 |
|---|---|
| Graham Number | (PB)5.07 vs (PE)23.77 |
| Over / Under Value Percentage | 356.98% vs -12.12% |
| Dividend Yield | 0.00% |
| Dividend Date | None |
| Symbol | APLS |
| AssetType | Common Stock |
| Name | Apellis Pharmaceuticals Inc |
| Description | Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company based in Waltham, Massachusetts, focused on developing innovative therapies targeting the complement system for autoimmune and inflammatory diseases. The company boasts a promising pipeline, highlighted by its lead investigational product, which aims to address significant unmet medical needs and transform treatment paradigms for patients with complex conditions. With a strong commitment to advancing the science of complement inhibition, Apellis is strategically positioned to make significant contributions to the biopharmaceutical sector and enhance patient outcomes. |
| CIK | 1492422 |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | BIOTECHNOLOGY |
| Address | 100 FIFTH AVENUE, WALTHAM, MA, UNITED STATES, 02451 |
| OfficialSite | https://apellis.com |
| FiscalYearEnd | December |
| LatestQuarter | 2025-09-30 |
| MarketCapitalization | 3178313000 |
| EBITDA | 82083000 |
| PERatio | 69.78 |
| PEGRatio | None |
| BookValue | 3.171 |
| DividendPerShare | None |
| EPS | 0.36 |
| RevenuePerShareTTM | 8.09 |
| ProfitMargin | 0.0443 |
| OperatingMarginTTM | 0.487 |
| ReturnOnAssetsTTM | 0.0513 |
| ReturnOnEquityTTM | 0.141 |
| RevenueTTM | 1016397000 |
| GrossProfitTTM | 605049000 |
| DilutedEPSTTM | 0.36 |
| QuarterlyEarningsGrowthYOY | 0 |
| QuarterlyRevenueGrowthYOY | 1.33 |
| AnalystTargetPrice | 35 |
| AnalystRatingStrongBuy | 3 |
| AnalystRatingBuy | 10 |
| AnalystRatingHold | 7 |
| AnalystRatingSell | 1 |
| AnalystRatingStrongSell | 0 |
| TrailingPE | 69.78 |
| ForwardPE | 46.3 |
| PriceToSalesRatioTTM | 3.127 |
| PriceToBookRatio | 7.92 |
| EVToRevenue | 3.123 |
| EVToEBITDA | 34.0 |
| Beta | 0.36 |
| 52WeekHigh | 35.57 |
| 52WeekLow | 16.1 |
| 50DayMovingAverage | 23.16 |
| 200DayMovingAverage | 21.91 |
| SharesOutstanding | 126525000 |
| SharesFloat | 89571000 |
| PercentInsiders | 13.639 |
| PercentInstitutions | 103.758 |
| ExDividendDate | None |
| etoro | 1 |
| dateChecked | 2026-02-19 22:18:09 |
| fresh | 1 |